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Neuroinvasive herpesviruses display a remarkable propensity to enter
the nervous system of healthy individuals in the absence of obvious
trauma at the site of inoculation. We document a repurposing of
cellular ubiquitin during infection to switch the virus between two
invasive states. The states act sequentially to defeat consecutive host
barriers of the peripheral nervous system and together promote the
potent neuroinvasive phenotype. The first state directs virus access to
nerve endings in peripheral tissue, whereas the second delivers virus
particles within nerve fibers to the neural ganglia. Mutant viruses
locked in either state remain competent to overcome the corresponding barrier but fail to invade the nervous system. The herpesvirus
“ubiquitin switch” may explain the unusual ability of these viruses to
routinely enter the nervous system and, as a consequence, their prevalence in human and veterinary hosts.
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erpesviruses such as herpes simplex virus type 1 (HSV-1)
and pseudorabies virus (PRV) routinely enter the peripheral
nervous system following casual contact between infected and
uninfected individuals. Recent findings have provided insights
into this complex phenotype, but the molecular mechanisms
directing nervous system invasion are poorly understood (1–5).
A critical effector of this process is a conserved herpesvirus deubiquitinase (DUB) (a cysteine protease that removes ubiquitin from
target posttranslationally modified proteins) (6–8). The DUB is
housed in the amino terminus of the pUL36 protein (protein
encoded by the 36th open reading frame in the unique-long segment of the viral genome), amounting to less than 10% of the total
mass of this large (>250 kDa) structural component of the virion
(9). pUL36 is attached directly to the icosahedral capsid shell of
these enveloped viruses (10–12) and, due to its location between the
capsid and envelope, is referred to as a herpesvirus tegument protein. Upon virus entry into a cell, pUL36 becomes exposed to the
cytosol (4, 13, 14) and directs delivery of the capsid and its DNA
content to the nucleus (2, 15–19). Following replication, pUL36 is
also essential for viral assembly and egress (20–22).
The presence of the pUL36 DUB on the exposed surface of the
intracellular viral particle suggests that removal of ubiquitin from
cellular cytosolic proteins, or from the virus particle itself, is instrumental for these viruses to transmit between peripheral tissues and
the neurons that innervate them (8). This necessarily implicates the
prior addition of ubiquitin as a factor in disease progression, either as
part of the virus neuroinvasive program or as a cellular defense
mechanism that is overcome by the DUB. Although several substrates of the DUB have been identified, how this enzyme promotes
the potent neuroinvasive property of these viruses is unknown
(23–30). To elucidate the role of the DUB, we set out to examine
the role of ubiquitination during neuroinvasive herpesvirus infection. We report that ubiquitin addition and removal from a
conserved lysine residue in pUL36 switches PRV between two
invasive states that act successively to promote virus dissemination into the peripheral nervous system. Supporting evidence
that the “ubiquitin switch” is conserved in HSV-1, and possibly
all neuroinvasive alphaherpesviruses, is provided.
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Results
Ubiquitination Promotes Retrograde Delivery of PRV Capsids to Cell
Bodies of Sensory Neurons. The requirement of the pUL36 DUB

during neuroinvasion may be either a protective mechanism that
stabilizes substrates by maintaining them in an unmodified state,
or part of a regulatory mechanism that switches proteins between
ubiquitinated and nonubiquitinated states. To discriminate between
these possibilities, ubiquitination was inhibited during PRV infection in a neuron culture model (Fig. 1A). Upon infection of
primary dorsal root ganglion (DRG) sensory neurons that were
pretreated with PYR41, an inhibitor of the E1 ubiquitin activating
enzyme, the delivery of PRV capsids to the nuclear rim was significantly reduced compared with the vehicle-treated control (Fig.
1B) (31). In contrast, interference was not observed in an epithelial
cell line nor following treatment of neurons with an inhibitor of
the related E1 activating enzyme of the ubiquitin-like modifier,
NEDD8 (Fig. 1 B and C) (32). These findings indicated a specific
role for ubiquitination in neurons during infection. Given that viral
protein pUL36 is an effector of the retrograde axonal transport that
delivers capsids to the neural soma, we investigated whether pUL36
was a target of ubiquitination during infection (2). A previous
report indicated that pUL36 is ubiquitinated during transient
overexpression when the DUB is inactivated by a catalytic
mutation (23); this also proved true during infection of epithelial cells (Fig. 1D). In contrast, there was no evidence of
pUL36 neddylation in this context, despite the prior finding
that the pUL36 DUB can cleave NEDD8 from substrates to
promote viral DNA replication (26).
Significance
The neuroinvasive herpesviruses cause a wide range of diseases in
humans and livestock. These viruses have the unusual ability to
routinely enter the mammalian nervous system following infection
of mucous membranes. Although infection is often asymptomatic,
the consequences of the resulting lifelong nervous system infections are not fully understood. This study uncovers two
opposing nervous system protective barriers that the virus
defeats by changing its properties during the course of infection. The molecular switch governing this change underlies
the herpesvirus neuroinvasive phenotype.
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Fig. 1. Ubiquitination promotes capsid delivery to neuronal nuclei. (A) Diagram
of capsid retrograde axonal transport and nuclear rim delivery. (B) Representative
images of capsids (UL25/mCherry tag) at nuclear rims of cultured DRG (Top) with
estimates of capsid numbers at nuclear rims at 3–4 hpi (Bottom) following pretreatment with DMSO (vehicle), PYR41 (10 μM), or MLN4924 (1 μM). Mean ± SD
are shown (***P < 0.001 based on Tukey’s multiple-comparison test). (Scale bar:
10 μm.) (C) Estimates of capsid numbers at nuclear rims at 3–4 hpi following infection of PK15 epithelial cells. (D) pUL36 was immunoprecipitated from PK15 cells
either mock-infected or infected with PRV expressing a GFP-pUL36 fusion at 8 hpi
and probed for GFP-pUL36, ubiquitin (Ub), or NEDD8. Input lysates were probed
for GFP-pUL36 and a cellular dynactin component (p150) as loading control.

A Conserved Lysine in pUL36 Is a Critical Virulence Determinant.

Mutational analysis was used to initially examine whether pUL36
ubiquitination promotes infection. Four lysines, the site of ubiquitin addition, that are invariant across the pUL36 homologs of
seven neuroinvasive herpesviruses were individually mutated to
arginine to prevent potential ubiquitination while maintaining the
positive charge of the amino acid side chain (Fig. 2A). The four
recombinant PRV strains propagated efficiently in epithelial cells,
but two (K442R and K1613R) exhibited moderate reductions in
spread (Fig. 2B). In contrast, defects associated with the K442R
and K1613R mutations were profound during infection of mice
(Fig. 2C). K442R-infected animals did not present symptoms
during the course of the experiment, which was terminated at 336 h
postinfection (hpi). The K1613R mutant was severely attenuated
relative to the wild type (WT), K963R, and K1299R viruses. Genetic repair of the K442R and K1613R mutations restored virus
spread and virulence to WT levels (Fig. 2 B and C).
To examine whether the virulence defect of the K442R mutant
correlated with a reduced capacity to infect neurons, capsid retrograde axonal transport in DRG cultured ex vivo was monitored
using live-cell fluorescence microscopy (Fig. 2D). In contrast to
Huffmaster et al.

WT, K1613R, or genetically repaired K442 virus, capsids of the
K442R mutant displayed aberrant motion in the form of frequent
stops and misdirected (anterograde) transport that together impaired the long-distance delivery of capsids to the cell body (Fig. 2D
and Movie S1). No corresponding defect was observed during epithelial infection (Fig. S1). The reduction in K442R capsid targeting
to the neural soma phenocopied broad inhibition of ubiquitination
during WT infection, implicating ubiquitin addition to pUL36 residue K442 as instrumental to neuronal infection (Figs. 1B and 2E).

used to determine whether PRV pUL36 K442 was, in fact, ubiquitinated during infection. The analysis measured the amount of
ubiquitin-like proteins (either ubiquitin, NEDD8, or ISG15) present on virus proteins isolated from HeLa cells infected for 8 h with
either HSV-1 or PRV, each encoding either a wild-type DUB (WT)
or a DUB catalytic mutant (ΔDUB) (Fig. S2). Modifications were
detected as posttryptic di-glycine conjugates on lysine side chains
(33). A ratio of ΔDUB:WT modification was determined for each
detected virus tryptic peptide, with values greater than 1 indicating
the peptide contained a lysine that was modified more frequently in
the absence of DUB activity during infection (Dataset S1). A
summary score of combined peptide ratios for individual virus
proteins was calculated, and a Pearson’s correlation analysis indicated a strong positive relationship between the two viruses (r =
0.87; Fig. 3A). The protein with the highest ΔDUB:WT value was
pUL36 itself, which had three targeted lysines in PRV: K442, K963,
and K1453 (Fig. 3B). Although the modifications identified by mass
spectrometry could be from either ubiquitin, NEDD8, or ISG15,
posttranslational modification at these pUL36 sites was consistent
with ubiquitin given that the DUB is not active against ISG15 (6,
26), and NEDD8 was not detected as a pUL36 conjugate during
infection with the ΔDUB virus (Fig. 1D). K963 (K1294 in HSV-1)
was not further examined as it was dispensable during PRV infection (Fig. 2 B and C) and was not enriched in the HSV-1 sample
(Fig. 3C). K1453 (K1789 in HSV-1) was also not pursued, as although ubiquitination at this site was enriched in the ΔDUB sample
during HSV-1 infection (Fig. 3C), the lysine is not conserved in
other neuroinvasive herpesviruses including HSV-2, which notably
encodes arginine at the equivalent position (Fig. S3). Only K442
(K636 in HSV-1) is positionally conserved across the neuroinvasive
alphaherpesviruses, was ubiquitinated during both HSV-1 and PRV
infection, and was hyperubiquitinated in HSV-1 and PRV in the
absence of an active pUL36 DUB (Fig. 3 and Fig. S3). These results
are consistent with the noted requirement for an active ubiquitination pathway during neuronal infection, with the critical substrate
mapping to K442 of PRV pUL36.
Lysine 442 Is Necessary for Retrograde Invasion and Spread Within
the Nervous System. To determine whether the defects associated

with the K442R mutation translated to reduced neuroinvasion in
a mammalian host, variants of PRV encoding an mCherry-capsid
fusion that serves as a fluorescent reporter were injected intraocularly into the aqueous humor of the rat eye anterior
chamber (AC) (Fig. 4A). Although not a natural route of infection,
the AC model confines the initial infection to intraocular tissues
that are bathed in the aqueous humor, including the iris, progressing to a well-defined invasion of the peripheral nervous system
(PNS) by retrograde axonal transport (34). This model was previously used to document the neuroinvasive defect of PRV
encoding a catalytically inactive DUB (8). At 44 hpi, both the
ΔDUB and K442R viruses had spread within the iris, approaching
but not equivalent to WT infection levels (Fig. 4B). Neuroinvasion
was monitored by imaging the innervating ipsilateral superior
cervical ganglion (SCG) at 48 hpi, which was sufficient time for WT
virus to infect this autonomic ganglion of the PNS (Fig. 4C).
Spread to SCG neurons only occurred following PRV replication
PNAS | October 13, 2015 | vol. 112 | no. 41 | 12819
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in innervated tissues of the eye, as a defective PRV mutant (ΔUL25)
that cannot spread cell to cell produced negligible infection of the
SCG, indicating that axon terminals in the eye are not exposed to the
aqueous humor (Fig. 4C) (35). The ΔDUB virus was incapable of
transmission to the SCG despite productive replication in the iris,
which is consistent with the prior observation that DUB activity is
required for PRV spread from the AC to the brain, and demonstrates that this established CNS neuroinvasive defect is due to an
upstream loss of PNS neuroinvasion (7, 8). The K442R virus phenocopied the DUB mutant demonstrating that ubiquitination, in
addition to deubiquitination, at K442 is critical for invasion of the
PNS. Intraocular AC injection of repaired viruses resulted in infection of the SCG that was indistinguishable from the WT (Fig. 4C).
To determine whether the loss of neuroinvasion with the K442R
mutant was due to a defect in epithelial-neuron transmission, virus
inoculum was injected directly into the superior colliculus (SC) of
the brain, which receives axonal projections from retinal ganglion
cells (RGCs) in the eye (Fig. 4D). In the absence of an epithelial
barrier, the ΔDUB virus replicated and spread within the SC,
reinforcing that DUB activity is dispensable for neurotropism but is
critical for neuroinvasion (Fig. 4E) (8). Furthermore, the DUB
mutant spread from the SC to the retina, confirming that the virus
was competent to travel retrogradely in axons. The K442R mutant
12820 | www.pnas.org/cgi/doi/10.1073/pnas.1512559112

Fig. 2. A conserved lysine in pUL36 is a virulence
determinant that sustains retrograde axonal transport. (A) Illustration of PRV pUL36. Positions of lysine
residues are noted with vertical bars, and the DUB is
shown in light gray with the position of the active-site
cysteine indicated. Four lysines conserved across seven
neuroinvasive herpesviruses are shown with local sequence alignments (GenBank JF797219, AJ004801,
AY665713, NC_001348, NC_004812, GU734771, and
Z86099). (B) Spread of viruses in PK15 epithelial cells
(n = 150 per sample; mean ± SD shown in red; ***P <
0.001 based on Tukey’s multiple-comparison test; rep,
genetic repair). (C) Kaplan–Meier presentation of
mouse survival following intranasal instillation of 106
plaque-forming units (PFU) of PRV (n = 10 for K442R
and K1613R; n = 5 for all others). (D) Frequency of
aberrant (nonretrograde) PRV axonal transport in
cultured DRG sensory neurons 30–60 min postinfection
(three independent experiments; n > 100 viral particles
per sample; mean values ± SEM; *P < 0.05, two-tailed
unpaired t test). (E) The number of fluorescent capsids
at nuclear rims of cultured DRG (Left, representative
images) was estimated (Right) at 3–4 hpi. (Scale bar:
10 μm.)

also remained neurotropic and spread within the SC, but did not
transmit retrogradely within the axons of the optic nerve to the retina
(Fig. 4E). The inability of the K442R mutant to transmit retrogradely
from AC to SCG (indirect neuronal exposure) and from CNS to
retina (direct neuronal exposure) was consistent with the noted defect in retrograde axonal transport (Fig. 2 D and E) and distinguished this neuroinvasive effector function from that of the DUB.
Discussion
Neurotropic herpesviruses such as HSV-1 and PRV exhibit profound, yet subtle, neuroinvasive properties. Infections typically
begin in exposed mucosal tissue, with newly replicated viral particles rapidly transmitting within axons of innervating neurons and
resulting in the establishment of lifelong latent infections in sensory
and autonomic ganglia of the PNS. This feat is remarkable given that
most unrelated viral infections occur one cell junction away from
peripheral nerves, yet few viruses invade the nervous system. Of
those that do, neuroinvasion is infrequent (i.e., poliovirus, measles
virus, mumps virus, West Nile virus, Japanese encephalitic virus, and
Chandipura virus) or occurs following an animal bite (i.e., rabies
virus). In the case of the latter, mechanical tissue disruption at the
site of inoculation bypasses intrinsic protective barriers in the skin
and increases retrograde transport in damaged axons as part of a
Huffmaster et al.
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Fig. 3. Ranking of ubiquitinated viral proteins as pUL36 DUB substrates.
(A) Comparison of PRV and HSV-1 mass spectrometry datasets as detailed for
PRV (B) and HSV-1 (C). Tryptic peptides containing lysine di-glycine conjugates from lysates of HeLa cells infected with WT or DUB-inactivated PRV or
HSV-1 were immunoprecipitated and examined by mass spectrometry. For
each WT and ΔDUB pair, a peptide ratio (ΔDUB/WT) was determined and a
value of 1 was subtracted. A summary score for each viral protein was then
calculated by summing its peptide ratios. Each point on the graph represents
one viral protein summary score (A), with greater values indicating the
tendency of the protein to be modified in the absence of DUB activity. Only
proteins that had modified lysines in both PRV and HSV-1 were plotted.
A Pearson correlation analysis indicated a positive relationship between the
two viruses (r = 0.87). (B and C) Positive peptide ratios were summed for
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peripheral nerve repair response (36, 37). The concept that tissue
trauma can increase the susceptibility of the nervous system to
neurotropic viruses is best documented for poliovirus, which is rarely
neuroinvasive except when provoked by tissue injury (38–40). The
near impenetrability of the nervous system in healthy tissue indicates
that effective intrinsic barriers to infection exist between peripheral
tissues and the PNS. However, these barriers are seemingly ineffective against the neuroinvasive herpesviruses.
We report that PRV repurposes the cellular ubiquitin pathway as
a means to switch the virus between two invasive states. Each state
is capable of overcoming an intrinsic barrier that normally protects
the PNS from infection, but neither state alone is sufficient to
promote neuroinvasion (Fig. 5). A combination of genetic analysis
and mass spectrometry data pinpointed K442 in the capsid-bound
tegument protein, pUL36, as the relevant site of ubiquitination and
deubiquitination that modulates the virus state. PRV, which is
highly neurovirulent in rodent infection models, became avirulent
and incapable of PNS invasion when encoding a single K442R codon change that prevented ubiquitination at this site. By capitalizing
on a well-defined PRV ocular infection model, the opposing phenotypes of the ubiquitin switch became apparent: addition and removal of ubiquitin at K442 was consistent with alternating the virus
between an axon-targeting mode within peripheral tissues (DUB
dependent) and a sustained retrograde microtubule trafficking state
following entry into axons (ubiquitination/K442 dependent).
The absolute requirement of the ubiquitin switch in coordinating the larger neuroinvasive phenotype indicates that the
intrinsic barriers protecting nerve endings in peripheral tissues
are diametrically opposed, and we suggest that this opposition
hinders the evolution of neuroinvasive properties, as virus adaptations that overcome one barrier will be detrimental to the
ability of a virus to overcome the opposing barrier. Given the
role of pUL36 in microtubule-based transport, it seems likely
that microtubule trafficking may be the source of the barrier
opposition (2). Preventing ubiquitination at K442 moderately
reduced viral spread in nonneuronal cells based on plaque assay,
but severely impaired microtubule-based retrograde delivery of
PRV in axons in explanted sensory ganglia and eliminated retrograde spread in vivo. The enhancement of retrograde microtubule transport that benefits PRV axonal transport is likely
detrimental for spread from epithelia to nerve endings, as
indicated by the ΔDUB phenotype, possibly by misdirecting virions from sites of epithelial/axonal contact. The benefit afforded
by the DUB in epithelial cells, why the DUB activity is not
detrimental within axons, and identifying the E3 ubiquitin ligase
that targets pUL36 are important topics for future investigation.
Because the DUB and K442 are conserved elements of pUL36
across the neuroinvasive herpesviruses, the robust neuroinvasion
exhibited by these Alphaherpesvirinae subfamily members are likely
based upon the ubiquitin switch described here with PRV. In particular, the comparative mass spectrometry analysis of HSV-1 and
PRV ubiquitination included in this report indicates that the conserved K442 site (K636 in HSV-1) is ubiquitinated and serves as a
DUB substrate for both viruses. Thus, the ubiquitin switch provides
a framework for understanding how a subset of herpesviruses are
capable of routinely invading the mammalian nervous system.
Materials and Methods
Cells and Virus Strains. Vero and PK15 epithelial cell lines were maintained
in Dulbecco’s modified Eagle medium (DMEM) supplemented with 10% (vol/vol)

each corresponding protein and plotted in rank order from poorest DUB
substrate (Top) to greatest (Bottom). Black bars indicate conserved substrates in PRV and HSV-1. *Proteins with summed ratios < 1 (i.e., modified
but not DUB substrates). The number of di-glycine modified lysines detected
per protein is indicated in parentheses. Insets show pUL36 peptides having a
ratio > 1 (dotted vertical lines, significance threshold of 1.5).
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Fig. 4. The herpes DUB and lysine substrate promote serial stages of neuroinvasion. (A and D) Two models of PRV retrograde axonal transport examined in this study
(AC, anterior chamber; RGC, retinal ganglion cells; SC, superior colliculus; SCG, superior cervical ganglion). (A) Nerve endings are shielded by ocular tissue (iris) and not
directly exposed to viral inoculum. (B and C) Representative images of the iris (B) and SCG (C) following intraocular injection of PRV strains encoding a mCherry-capsid
reporter into the AC and retrograde transport to the SCG, with amount of infection based on fluorescent cell number indicated below. (D) Neurons and axons are
directly exposed to viral inoculum. (E) Representative images and quantitation following intracranial injection into the SC and retrograde transmission to RGC of the
contralateral eye. Microelectrode tracks are outlined in SC injection images to distinguish inoculum from viral spread. (Scale bars: 50 μm.)

bovine growth serum. HeLa cells were freshly obtained from the ATCC and
maintained in DMEM supplemented with 10% (vol/vol) FBS. Bacterial artificial
chromosome (BAC) infectious clones derived from PRV pBecker3 were transfected
into PK15 cells as described previously (41). HSV-1 infectious clones derived from

the pYEbac102 BAC (42) were transfected into Vero-Cre cells as previously described (4). The resultant virus stocks were passaged once to create working stocks.
Titers and single-step propagation kinetics were determined by plaque assays on
PK15 (PRV) or Vero (HSV-1) cells as described previously (4, 43) (Tables S1 and S2).

State 2
Persistent retrograde axonal transport
(ubiquitin addition is essential)

State 1
Transmission to nerve terminals
(deubiquitinase is essential)
E1
Ub

Inhibited by catalytic inactivation
of the pUL36 DUB

Ub
Ub

nucleus

Ub

Inhibited by E1 antagonist or mutation of the
pUL36 K442 ubiquitin acceptor site

Transmission within epithelium is
state independent

Fig. 5. Ubiquitin switch model of herpesvirus neuroinvasion. The large tegument protein (pUL36) encodes a deubiquitinase (DUB) activity and a ubiquitin
addition site (K442 in PRV), both of which are essential for virus invasion of the nervous system from peripheral tissues. The DUB and K442 acceptor site
together constitute a molecular switch that alternates the virus between an axon targeting mode (state 1), and a sustained retrograde transport mode (state
2) that is required for the long-distance delivery of viral particles within nerve fibers to the peripheral ganglia.
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Live-Cell Fluorescence Microscopy. Imaging of axonal transport and capsid
accumulation at neuronal nuclei was performed using primary cultured neurons
from embryonic chicken [embryonic day 8 (E8) to E10] DRGs, as previously described (13). See SI Materials and Methods for further details.

Mass Spectrometry (UbiScan). Approximately 2.0 × 108 HeLa cells were infected
at MOI of 50 with either WT or DUB mutant PRV or HSV-1 and collected at 8 hpi
for label-free UbiScan analysis (33). Detailed methods are in SI Materials and
Methods. Raw and fold-change sorted data are combined in Excel format in
Dataset S1.

In Vivo Inoculation of Virus. All procedures conformed to NIH guidelines for
work with laboratory animals and were approved by the Institutional Animal
Care and Use Committee of the University of Nebraska, Lincoln. See SI Materials
and Methods for further details.
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Immunoprecipitation and Western Blotting. PK15 cells were mock infected or
infected at a multiplicity of infection (MOI) of 50 with recombinant viruses
encoding GFP-pUL36 fusions. Lysates were prepared at 8 hpi as described previously (44). More details can be found in SI Materials and Methods.
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Cells and Virus Strains. Vero and PK15 epithelial cell lines were
maintained in Dulbecco’s modified Eagle medium (DMEM)
supplemented with 10% (vol/vol) bovine growth serum. HeLa
cells were freshly obtained from the ATCC and maintained in
DMEM supplemented with 10% (vol/vol) FBS. Bacterial artificial chromosome (BAC) infectious clones derived from PRV
pBecker3 were transfected into PK15 cells as described previously (41). HSV-1 infectious clones derived from the pYEbac102 BAC (42) were transfected into Vero-Cre cells as
previously described (4). The resultant virus stocks were passaged once to create working stocks, and titers were determined
by plaque assays on PK15 (PRV) or Vero (HSV-1) cells as described previously (4, 43). The complete list of recombinant viruses used in this study is provided in Table S1, along with the
primers used in their production by the en passant two-step recombination procedure in Table S2.
Viral Propagation Kinetics and Plaque Size Analysis. Nonfluorescent
PRV variants were used for single-step growth and plaque size
analysis as previously described (43). Briefly, 4.3 × 105 PK15 cells
were infected at a MOI of 10 and the supernatants and cellassociated virus were collected and frozen at −80 °C at 2, 5, 8, 12,
and 24 h postinfection (hpi). Samples were thawed, sonicated,
and titered on PK15 cells. For plaque diameter analysis, ∼200
PFU per virus were used to infect PK15 cells. At 72 hpi, plaquing
medium was removed and cells were stained with neutral red dye
(Sigma-Aldrich) and scanned at 2,000 dpi on a flatbed scanner.
MetaMorph software (Molecular Devices) was used to measure
plaque diameters. WT plaques were set to 100%, and mutant
virus plaque diameters were plotted as %WT. Significance was
determined using Tukey’s multiple-comparison test (***P < 0.001).
Immunoprecipitation and Western Blotting. Approximately 4.3 ×
105 PK15 cells were mock infected or infected at a MOI of 50
with recombinant PRV encoding GFP-pUL36 fusions (Table
S1). Lysates were prepared as described previously (44). Briefly,
cells were lysed 8 hpi in SDS lysis buffer [1% SDS, 0.5% Nonidet
P-40, 10% (vol/vol) glycerol, 250 mM NaCl, 3 mM EDTA,
20 mM Tris (pH 8.0)] supplemented with 20 mM N-ethylmaleimide,
5 mM iodoacetate, 1 mM phenylmethylsulfonyl fluoride, 25 mM
sodium fluoride, 1 mM sodium orthovanadate, and Sigma Protease
Inhibitor Mixture (Sigma-Aldrich). Lysates were centrifuged at 4 °C
for 10 min at 13,000 × g to remove cell debris. Supernatant was
precleared using 10 μL of Protein G Plus Protein A Agarose Beads
(Merck-Millipore). Immunoprecipitations were performed using
the rabbit serum polyclonal anti-GFP (Life Technologies) conjugated
to Protein G Plus Protein A Agarose Beads. Immunoprecipitated
protein was eluted using 2× final sample buffer [62.5 mM Tris
(pH 6.8), 10% (vol/vol) glycerol, 0.01% bromophenol blue, 2%
(wt/vol) SDS, 10% (vol/vol) β-mercaptoethanol] and boiled for
5 min. Samples were separated on 5% SDS/PAGE. Proteins
were transferred to 0.45-μm nitrocellulose membranes. Ubiquitin
was detected using the mouse monoclonal anti-Ub clone FK2
(Enzo Life Sciences). NEDD8 was detected using rabbit serum
polyclonal anti-NEDD8 (Cell Signaling Technology). GFP-pUL36
was detected using rabbit serum polyclonal anti-pUL36 raised
against the PRV pUL36 peptide QPSQQRPPEAPWTWPEPRD
(45). PTMScan lysates were separated on a 4–20% polyacrylamide
gradient, and VP5 was detected using the mouse monoclonal antiVP5 clone H1.4 for HSV-1 (Biodesign International) or mouse
monoclonal anti-VP5 clone 3C10 for PRV (a generous gift from
Huffmaster et al. www.pnas.org/cgi/content/short/1512559112

Lynn Enquist, Princeton University, Princeton). α-Tubulin was detected with the mouse monoclonal anti–α-tubulin clone DM1A
(Abcam). Detection was performed using a LI-COR Odyssey Fc
imaging system with donkey anti-rabbit IRDye 680RD or goat antimouse IRDye 800CW secondary antibodies (LI-COR Biosciences).
Live-Cell Fluorescence Microscopy. Imaging of axonal transport and
capsid accumulation at neuronal nuclei was performed using
primary cultured neurons from embryonic chicken (E8–E10)
dorsal root ganglia (DRGs), as previously described (13). Briefly,
DRG explants were grown on poly-DL-ornithine and laminintreated coverslips in 2 mL of F12 media (Invitrogen) containing
nutrient mix: 0.08 g/mL BSA fraction V powder (VWR), 0.4 mg/mL
crystalline bovine pancreas insulin (Sigma-Aldrich), 1:2,500
1.0 mg/mL sodium selenite (VWR), 4 μg/mL transferrin (Intercell
Technology), and 5 μL of 0.05 mg/mL nerve growth factor (SigmaAldrich). Explants were cultured for 2–3 d before infection with
PRV variants encoding the pUL25/mCherry fusion at 5.0 × 107 PFU
(Table S1). Time-lapse images were captured using an inverted
wide-field Nikon Eclipse TE2000-U microscope fitted with a 60×/1.4
numerical aperture (N.A.) objective and a CascadeII:512 electronmultiplying charge-coupled device (EM-CCD) (Photometrics). The
microscope was housed in a 37 °C environmental box (In Vivo
Scientific). Transport events were imaged from 30 to 60 min postinfection. Moving particles were monitored by time-lapse fluorescence microscopy at 10 frames per s (100-ms exposures) for 200
frames. Particle velocities were determined using the kymograph
function of the MetaMorph software package (Molecular Devices).
Kymographs were generated using the multiline tool with a width of
20 pixels and average background subtraction. Entire particle paths,
whether moving, stalled, or reversing, were traced within the kymograph using the “Multi-line” tool. Data were filtered postanalysis
to only include velocities of runs ≥0.2 μm. Fraction of time stopped,
in anterograde motion, and in retrograde motion were calculated for
each particle by dividing the total time the particle was either
stopped or moving by the total time the particle was imaged. Greater
than 100 particles were analyzed per virus for three replicate experiments, and an average value was calculated for each virus.
Values reported represent the mean ± SEM of the average values
obtained. Significance was determined using Student’s two-tailed
unpaired t test (*P < 0.05). Graphs were created in GraphPad Prism
4 (GraphPad Software).
For assessing delivery of capsids to the nucleus, either PK15
epithelial cells or DRG explants were infected with PRV variants
encoding pUL25/mCherry (Table S1) and imaged between 2 and 3,
and 3 and 4 hpi, respectively, using a Nikon Ti inverted microscope
fitted with a 100×/1.45 N.A. objective (Nikon Instruments) and
coupled to a CSU-W1 confocal head (Yokogawa Electric Corporation) and a CascadeII:1024 EM-CCD (Photometrics). Illumination was provided by a Sapphire 561 laser (Coherent) and custom
laser launch (Solamere Technology Group, Inc.). Either differential
interference contrast (DRG) or 1.0 μg/mL Hoechst 33342 (PK15)
(Life Technologies) was used to identify nuclear periphery. MetaMorph software was used to estimate the number of fluorescent
capsids per nuclear rim. First, a threshold was applied to remove
background from the images, and next the total emissions from
pUL25/mCherry capsids were measured using an elliptical region
that included the nuclear periphery (nuclear interiors were not included as they were below threshold), and the integrated fluorescence intensity of each nuclear region was divided by the average
intensity of three isolated intracellular capsids. The latter normalized
the nuclear intensity values to a per-capsid equivalency. Ubiquitin E1
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activating enzyme inhibitor (UBA1 inhibitor) PYR41 was purchased
from Tocris, dissolved in DMSO, added to cells to a final concentration of 10 μM 1 h before infection, and maintained throughout
the infection. NEDD8 E1 Activating Enzyme Inhibitor (NAE Inhibitor) MLN4924 was purchased from Boston Biochem, dissolved
in DMSO, and added to cells to a final concentration of 1.0 μM 6 h
before infection and maintained throughout the infection.
In Vivo Inoculation of Virus. All procedures conformed to NIH
guidelines for work with laboratory animals and were approved by
the Institutional Animal Care and Use Committee of the University
of Nebraska, Lincoln. Intranasal inoculation was performed as
previously described (43). Briefly, male CD-1 mice (6 wk old;
Charles River) were maintained for at least 2 wk under a 12:12 h
light/dark cycle, two to three mice per cage with food and water
freely available. Intranasal application of PRV was administered to
animals anesthetized by 2.5–5.0% isoflurane inhalation. Viral
stocks were maintained frozen at −80 °C and used immediately
after being thawed. Each animal received 5 μL of PRV (0.5–1.0 ×
106 PFU) in each nostril. Behavior was continuously video monitored
with images captured every 10 min. Survival times postinoculation were rounded to the nearest hour. Intraocular and intracranial injections of male Long–Evans rats, isolation of nervous
tissues, and processing for fluorescence imaging were as previously
described (8).
Mass Spectrometry (UbiScan). Approximately 2.0 × 10 HeLa cells
8

were infected at MOI of 50 with either WT or DUB mutant PRV
or HSV-1 (Table S1). At 8 hpi, cells were washed with cold PBS
and lysed in urea lysis buffer [20 mM Hepes (pH 8.0), 9 M urea,
1 mM sodium orthovanadate, 2.5 mM sodium pyrophosphate,
and 1 mM β-glycerol-phosphate]. Lysates were sonicated to shear
genomic DNA and centrifuged at 4 °C for 15 min at 20,000 × g to
pellet cell debris. The supernatants were frozen at −80 °C and
shipped on dry ice overnight to Cell Signaling Technology for labelfree UbiScan analysis (33). The cell extracts were digested with
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trypsin and lyophilized via solid-phase extraction on a C18 column.
Reconstituted peptides were incubated with a K-e-GG remnant
motif antibody (Cell Signaling Technology) and immobilized on
protein A-agarose beads. The resin was washed to remove unbound
peptides, and peptides immunoprecipitated with the K-e-GG
remnant motif antibody were eluted. Each sample was divided in
half used for independent liquid chromatography–tandem mass
spectrometry (LC-MS/MS) runs. Peptides were loaded directly onto
a 10 cm × 75-μm PicoFrit capillary column packed with Magic C18
AQ reversed-phase resin. The column was developed with a 72-min
linear gradient of acetonitrile in 0.125% formic acid delivered at
280 nL/min. LC-MS/MS analysis was performed on a LTQ-OrbitrapElite, using electrospray ionization–collision-induced dissociation. MS
parameter settings were as follows: MS run time, 96 min; MS1 scan
range (300–1500); top 20 MS/MS (min signal 500, isolation width
2.0, normalized coll. energy 35, activation-Q 0.25, activation time
20, lock mass 371.101237, charge state rejection enabled, charge
state 1+ rejected, dynamic exclusion enabled, repeat count 1, repeat
duration 35, exclusion list size 500, exclusion duration 40, exclusion
mass width relative to mass, exclusion mass width 10 ppm). MS/MS
spectra were evaluated using SEQUEST 3G and the SORCERER
2 platform from Sage-N Research (version 4.0). Searches were
performed against the human database (National Center for Biotechnology Information release date, 6/27/2011); Suid herpesvirus 1
strain Becker database (release date, 11/2/2011) for PRV samples;
and human herpesvirus 1 strain F database (release date, 4/27/2010)
for HSV-1 samples with a mass accuracy of ±50 ppm for precursor
ions and 1 Da for product ions. Results were filtered with mass
accuracy of ±5 ppm on precursor ions and presence of the intended
modification K-e-GG. A 5% default false-positive rate was used to
filter the SORCERER results. Results were further filtered based
on the analytical variation (percent coefficient of variation) and
intensity values being above background in at least one sample.
Raw and fold-change sorted data are combined in Dataset S1.
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Fig. S1. K442 is dispensable for nuclear rim delivery and propagation in epithelial cells. (A) The number of fluorescent capsids at nuclear rims was estimated 2
hpi in PK15 cells. Representative images document that while the majority of input viral particles remain in proximity of cell surfaces, a fraction have traversed
the cytoplasm and are now localized at the nuclear periphery. Mean ± SD of capsid fluorescence at nuclear rims are shown with statistics based on an unpaired
t test. (Scale bar: 10 μm.) (B) Propagation kinetics of the K442R mutant on PK15 cells (MOI 10) relative to WT and repaired PRV. PFU, plaque-forming units.
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Fig. S2. Monitoring of infection by major capsid protein (VP5) expression. HSV-1– and PRV-infected HeLa lysates used for Fig. 3 were blotted for HSV-1 and
PRV VP5 and α-tubulin (loading control). WT viruses (DUB+); DUB inactive viruses (DUB−; HSV-1 C40A and PRV C26A).

Fig. S3. Local alignments of pUL36 lysines from seven neuroinvasive herpesviruses annotated with results from UbiScan mass spectrometry analysis of PRV and
HSV-1 pUL36. Illustration of pUL36 lysine residues in PRV (Top, 49 lysines) and HSV-1 (Bottom, 48 lysines). Lysines are represented as vertical lines, with
ubiquitinated lysines (Ub) indicated by amino acid position. Lysines that are DUB autocatalytic substrate sites are indicated in red. Local sequence alignments
for the three lysines studied (PRV K442, K963, and K1299) are shown with corresponding HSV-1 lysines indicated. An alignment for a fourth lysine that is a DUB
substrate in PRV and HSV-1, PRV K1453, is also provided. Alignment details: conserved amino acids are in bold with dark gray background, and amino acids
with similar properties have a light gray background.
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Table S1. Strains used in this study
Strain
PRV-GS999
PRV-GS4957
PRV-GS5951
PRV-GS5317
PRV-GS5531
PRV-GS5380
PRV-GS5381
PRV-GS4284
PRV-GS4747
PRV-GS5971
PRV-GS5112
PRV-GS5933
PRV-GS5270
PRV-GS5507
PRV-GS5508
PRV-GS5555
HSV1-GS4553
HSV1-GS5553

mCherry*

GFP

Encoded UL36 product†

—
—
—
—
—
—
—
pUL25
pUL25
pUL25
pUL25
pUL25
pUL25
pUL25
pUL25
—
pUL25
pUL25

—
—
—
—
—
—
—
—
—
—
—
—
—
GFP-pUL36
GFP-pUL36
CMV > GFP‡
—
—

WT
K442R
K442 (GS4957 repair)
K1613R
K1613 (GS5317 repair)
K963
K1299
WT
C26A
C26 (GS4747 repair)
K442R
K442 (GS5112 repair)
K1613R
WT
C26A (ΔDUB)
WT
WT
C40A (ΔDUB)§

Titer, PFU/mL

Source

×
×
×
×
×
×
×
×
×
×
×
×
×
×
×
×
×
×

Smith and Enquist (41)
Current study
Current study
Current study
Current study
Current study
Current study
Bohannon et al. (43)
Current study
Current study
Current study
Current study
Current study
Current study
Current study
Current study
Current study
Current study

3.0
1.0
3.0
6.3
1.6
2.7
1.4
2.2
2.1
2.5
1.1
2.7
3.0
1.5
3.5
1.4
4.8
4.5

109
109
109
108
109
109
109
109
108
109
109
109
108
109
108
108
108
108

*mCherry was fused in-frame between pUL25 amino acids 42–43 for PRV and 50–51 for HSV-1.
†
Amino acid numbers are based on PRV strain Becker (GenBank JF797219) and HSV-1 strain F (GenBank GU734771 and KM222724).
‡
Soluble GFP cassette driven by a CMV promoter was inserted into the US4 gene. This virus is also deleted for the UL25 gene.
§
The catalytic cysteine at position 40 has been previously referred to as C65 based on an upstream in-frame ATG being assigned amino
acid position 1.
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Table S2. En passant primer pairs used to construct PRV and HSV-1 recombinant viruses made for this study
Strain

PCR template

Primers

GS4957, GS5112

pEP-KanS2

GS5951, GS5933

pEP-KanS2

GS5317, GS5270

pEP-KanS2

GS5531

pEP-KanS2

GS5380

pEP-KanS2

GS5381

pEP-KanS2

GS4747, GS5508

pEP-KanS2

GS5971

pEP-KanS2

5′-GCGCTGCTGGACGTGGCCGGCGACGACGCGTCCGCGCCCGTGGCCAGGCTGGCGCTGGTCGCGAGGATGACGACGATAAGTAGGG
5′-GGCCTCGTTCGCGGGCCGCGCGACGCGCGCCGCGACCAGCGCCAGCCTGGCCACGGGCGCGGACAACCAATTAACCAATTCTGATTAG
5′-GCGCTGCTGGACGTGGCCGGCGACGACGCGTCCGCGCCCGTGGCCAAGCTGGCGCTGGTCGCGAGGATGACGACGATAAGTAGGG
5′-GGCCTCGTTCGCGGGCCGCGCGACGCGCGCCGCGACCAGCGCCAGCTTGGCCACGGGCGCGGACAACCAATTAACCAATTCTGATTAG
5′-AACGTGCCCGTGGAGTACCAGGTGTGCTACCGCGCGGTCGGCGACAGACTGGCGGCCATGCTGAGGATGACGACGATAAGTAGGG
5′-CGGGCGCAGCTCGGCGCCCTCGTCGGTGCACAGCATGGCCGCCAGTCTGTCGCCGACCGCGCGCAACCAATTAACCAATTCTGATTAG
5′-AACGTGCCCGTGGAGTACCAGGTGTGCTACCGCGCGGTCGGCGACAAGCTGGCGGCCATGCTGAGGATGACGACGATAAGTAGGG
5′-CGGGCGCAGCTCGGCGCCCTCGTCGGTGCACAGCATGGCCGCCAGCTTGTCGCCGACCGCGCGCAACCAATTAACCAATTCTGATTAG
5′-CTGGAGGTGGCGCGCGCGGCCGCCGTGGAGGAGCCGCAGCTGCAGAGAATGGCGCTCGCGGCGAGGATGACGACGATAAGTAGGG
5′-GGCCGCCTCCAGCTCGCCGACGCGCTGGCGCGCCGCGAGCGCCATTCTCTGCAGCTGCGGCTCCAACCAATTAACCAATTCTGATTAG
5′-GCGGCGGCGCGCGACCGCGACGGGGCCCTCGAGCTGGCCAACCTCAGAAACCTGCTGCGGGTGAGGATGACGACGATAAGTAGGG
5′-GTCGATGTTGAGCGAGGCCGGCGGCGGCGTCACCCGCAGCAGGTTTCTGAGGTTGGCCAGCTCCAACCAATTAACCAATTCTGATTAG
5′-GGCTATCGTAATCAGTATGACCCCGACCTGGGGCCCGGGTCGGGCGTCTCAGCGCTGCGCTCCTCCCTCAGGATGACGACGATAAGTAGGG
5′-CTCCACGCCGTTCGTGAAGACCAGGCGCAGGAAGGAGAGGGAGGAGCGCAGAGCTGAGACGCCCGACCCCAACCAATTAACCAATTCTGATTAG
5′-TCAGTATGACCCCGACCTGGGGCCCGGGTCGGGCGTCTCGTGCCTGCGCTCCTCCCTCTCCTTAGGATGACGACGATAAGTAGGG
5′-TCGTGAAGACCAGGCGCAGGAAGGAGAGGGAGGAGCGCAGGCACGAGACGCCCGACCCGGGCCCAACCAATTAACCAATTCTGATTAG
5′-AAAGATTTTTCCCCCACGCGCGTGTGTTATTTCAGCCATGGTGAGCAAGGGCGAGGAG
5′-CATACTGATTACGATAGCCGACGACCACCGCGTCGGCCGTCTTGTACAGCTCGTCCATGC
5′-GGTGGGCGCGGTGATAAGGCGGCGCGCGGCGGCGCGCGGCCCATGTAACAGTTTGGCGTCTCCAGGATGACGACGATAAGTAGGG
5′-GCAGAGAAAGTACAGGAGGTCGTAGTCGCTGGAGACGCCAAACTGTTACATGGGCCGCGCGCCCAACCAATTAACCAATTCTGATTAG
5′-GTCGCCCGTCTTTAACCTCCCCCGGGAGACGGCGGCGGAGGTGAGCAAGGGCGAGGAG
5′-CGGCAGCCGCTGTGCGCTGGGCCTGTAGGACGACCACCTGCTTGTACAGCTCGTCCATGC
5′-GGTGCTCGGAACCAGTTCGCGCCCGACCTGGAGCCGGGGGGGTCGGTATCGGCTATGCGCTCGTCGCTGTCCTTAGGATGACGACGATAAGTAGGG
5′-GCGAGGGCCCACATCAAATATGAGGCTGAGAAAGGACAGCGACGAGCGCATAGCCGATACCGACCCCCCCGGCTCAACCAATTAACCAATTCTGATTAG

GS5507, GS5508
GS5555

GS4553, GS5553
GS5553

pEP-EGFP-in
pEP-KanS2

pEP-mCherry-in
pEP-KanS2

Underlined sequence indicates PCR template homology.
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Movie S1. Lysine 442-dependent sustained retrograde axonal transport. Example of data used for the analysis presented in Fig. 2D. WT PRV encoding a
mCherry-capsid reporter (Top) undergoes continuous retrograde transport in cultured sensory neurons. An equivalent virus encoding the K442R mutation
(Bottom) exhibits aberrant motion resulting from increased frequencies of stops and reversals.
Movie S1

Dataset S1. UbiScan PRV and HSV-1 peptide details in Excel format (8 hpi)
Dataset S1
This spreadsheet contains the raw and sorted results from mass spectrometry experiments used for the production of Fig. 3 and Fig. S3.
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